High-dose ascorbate sensitizes NSCLC and GBM cells to radio-chemotherapy

Posted by Dr Dan Carter, 6 May 2017 An April 2017 article in Cancer Cell adds further support for the use of IV Ascorbate to improve responses to conventional oncology treatments. Key points include: O2⋅−…